Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Lind

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Behavior Research Methods|April 5, 2017
DAVID: An open-source platform for real-time transformation of infra-segmental emotional cues in running speechLaura Rachman, Marco Liuni, Pablo Arias, et al.
Scandinavian Journal of Primary Health Care|February 5, 2021
Pre-screening and preventive quarantine likely explains the low SARS-CoV-2 prevalence among Norwegian conscriptsArne J Norheim, Einar K Borud, Andreas Lind, et al.
Vaccine|August 3, 2013
Boosters of a therapeutic HIV-1 vaccine induce divergent T cell responses related to regulatory mechanismsAndreas Lind, Kristin Brekke, Maja Sommerfelt, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2015
High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV InfectionChristian Prebensen, Thor Ueland, Annika E Michelsen, et al.
Innate Immunity|October 17, 2012
Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activationMarius Trøseid, Andreas Lind, Piotr Nowak, et al.
Journal of Virology|April 15, 2011
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responsesFrank O Pettersen, Eirik A Torheim, Anders E A Dahm, et al.
Indoor Air|February 28, 2022
Dispersion of SARS-CoV-2 in air surrounding COVID-19-infected individuals with mild symptomsJostein Gohli, Ane Marie Anderson, Arne Broch Brantsaeter, et al.
Viruses|June 27, 2025
Droplet Digital PCR or Real-Time PCR as a Method for Quantifying SARS-CoV-2 RNA in Plasma-Is There a Difference?Beathe Kiland Granerud, Mari Kaarbø, Huda Al-Baldawi, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 24, 2022
Inflammatory markers calprotectin, NETs, syndecan-1 and neopterin in COVID-19 convalescent blood donorsGeir Hetland, Magne Kristoffer Fagerhol, Veselka Petrova Dimova-Svetoslavova, et al.
Scientific Reports|July 7, 2022
EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infectionYunsung Lee, Espen Riskedal, Karl Trygve Kalleberg, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Behavior Research Methods|April 5, 2017
DAVID: An open-source platform for real-time transformation of infra-segmental emotional cues in running speechLaura Rachman, Marco Liuni, Pablo Arias, et al.
Scandinavian Journal of Primary Health Care|February 5, 2021
Pre-screening and preventive quarantine likely explains the low SARS-CoV-2 prevalence among Norwegian conscriptsArne J Norheim, Einar K Borud, Andreas Lind, et al.
Vaccine|August 3, 2013
Boosters of a therapeutic HIV-1 vaccine induce divergent T cell responses related to regulatory mechanismsAndreas Lind, Kristin Brekke, Maja Sommerfelt, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2015
High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV InfectionChristian Prebensen, Thor Ueland, Annika E Michelsen, et al.
Innate Immunity|October 17, 2012
Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activationMarius Trøseid, Andreas Lind, Piotr Nowak, et al.
Journal of Virology|April 15, 2011
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responsesFrank O Pettersen, Eirik A Torheim, Anders E A Dahm, et al.
Indoor Air|February 28, 2022
Dispersion of SARS-CoV-2 in air surrounding COVID-19-infected individuals with mild symptomsJostein Gohli, Ane Marie Anderson, Arne Broch Brantsaeter, et al.
Viruses|June 27, 2025
Droplet Digital PCR or Real-Time PCR as a Method for Quantifying SARS-CoV-2 RNA in Plasma-Is There a Difference?Beathe Kiland Granerud, Mari Kaarbø, Huda Al-Baldawi, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 24, 2022
Inflammatory markers calprotectin, NETs, syndecan-1 and neopterin in COVID-19 convalescent blood donorsGeir Hetland, Magne Kristoffer Fagerhol, Veselka Petrova Dimova-Svetoslavova, et al.
Scientific Reports|July 7, 2022
EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infectionYunsung Lee, Espen Riskedal, Karl Trygve Kalleberg, et al.
Pageof 5